Table 1.
Human subject list with pathological scores.
ID | Age | Sex | APOE | PMD | Diagnoses | B&B stage | Atherosclerosis* | Amyloid angiopathy* | Other pathology |
---|---|---|---|---|---|---|---|---|---|
591 | 78 | F | 33 | 5.5 | Normal CERAD 1A | 1 | |||
673 | 80 | F | 33 | 1.2 | Normal CERAD 1A | 1 | Mild | ||
981 | 74 | F | 24 | 4.7 | Normal CERAD 1B | 3 | Metastatic Carcinoma | ||
1035 | 72 | F | 33 | 30 | Normal CERAD 1B | 2 | |||
196 | 75 | M | 33 | 18.9 | Normal CERAD 1B | 1 | |||
381 | 78 | M | n/a | 9.8 | Normal CERAD 1A | 1 | |||
837 | 75 | M | 22 | 29 | Normal CERAD 1A | 1 | Lacunes | ||
543 | 72 | F | 34 | 3 | Normal CERAD 1A | 1 | |||
707 | 80 | M | 33 | 4.3 | Normal CERAD 1B | 1 | |||
795 | 81 | M | 34 | 7.2 | Normal CERAD 1B | 1 | Lacunes | ||
357 | 75 | M | 33 | 3 | AD | 3 | Mild | ||
347 | 77 | M | 33 | 16.8 | AD | 3 | |||
601 | 76 | F | 33 | 10.5 | AD | 3 | |||
602 | 78 | M | 34 | 0.8 | AD | 3 | Mild | ||
731 | 76 | F | 44 | 5.5 | AD | 3 | Mild | Mild | |
1054 | 75 | F | 34 | 20.1 | AD | 3 | Severe | Mild | |
1052 | 71 | M | 33 | 25.2 | AD | 6 | Mild | ||
1068 | 77 | M | 44 | 25.4 | AD | 6 | Mild | Mild | |
1560 | 74 | F | 34 | 20.5 | AD | 6 | |||
360 | 75 | F | 33 | 13.3 | AD | 6 | Mild | ||
1664 | 79 | F | n/a | 20.8 | AD | 6 | Moderate | Infarcts | |
49 | 75 | F | 34 | 24 | AD | 6 | Severe | ||
254 | 75 | M | 34 | 2.6 | AD | 6 | Moderate |
Pathological scores were analyzed by a pathologist for atherosclerosis and amyloid angiopathy using CERAD guidelines and NIA-Reagan criteria